RASBY 1.5MG INJECTION

RASBY 1.5MG INJECTION is used to prevent or treat hyperuricemia (high levels of uric acid in the blood) in patients who are undergoing cancer chemotherapy for leukemia, lymphoma, and solid tumor malignancies.

Yes, it is an important supportive therapy for patients undergoing chemotherapy to reduce the risk of complications associated with high levels of uric acid in the blood.

RASBY 1.5MG INJECTION are not indicated for those who have already developed acute gout or hyperuricemia due to conditions other than cancer chemotherapy.

It is advised to avoid certain medications, such as allopurinol, which is used to lower uric acid levels. Using allopurinol with RASBY 1.5MG INJECTION together can reduce the effectiveness of rasburicase.

RASBY 1.5MG INJECTION works by converting uric acid into allantoin, a more soluble compound that can be easily excreted by the kidneys. This reduces the levels of uric acid in the blood and prevents the development of hyperuricemia.

Yes, it is often used prophylactically in individuals who are at high risk for TLS due to their cancer chemotherapy.

There are no known interactions of RASBY 1.5MG INJECTION with other drugs.

Foods that are high in purines should be avoided, such as red meat, organ meats, and some seafood, which can increase uric acid levels and reduce the effectiveness of RASBY 1.5MG INJECTION. Avoid driving and operating heavy machinery if you feel tired or weak during this treatment. Certain activities or conditions that can trigger gout attacks, such as fasting, rapid weight loss, and stress, should also be avoided while taking Rasburicase. Dehydration can reduce the effectiveness of the medication and increase the risk of side effects, so it is necessary to drink plenty of fluids, especially water, while taking this medicine. Smoking can cause oxidative stress in the body, which can lead to an increase in uric acid levels. It is advised to avoid smoking or using tobacco products while undergoing treatment with RASBY 1.5MG INJECTION.

Rasburicase is a medication used to treat high levels of uric acid in the blood. It is the active ingredient in RASBY 1.5MG INJECTION, which makes it effective.

RASBY 1.5MG INJECTION is used in Oncology to prevent and treat Tumor Lysis Syndrome (TLS) during cancer treatment, a condition that occurs when cancer cells die and release their contents into the bloodstream.

The use of RASBY 1.5MG INJECTION during chemotherapy is important because it helps prevent Tumor Lysis Syndrome (TLS), a serious side effect of chemotherapy that can cause kidney failure, heart problems, and even death.